Location: New York, NY
CIK: 0001017645 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $2.148B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALKT | ALKAMI | 15,337,495 (+27.9%) | $240M (-13.1%) | 11.2% | $31.20 | -37.7% | COM | 01644J108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALHC | ALIGNMENT HEALTHCARE | 13,167,733 | $260M | 12.1% | $19.55 | +9.7% | — | 01625V104 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES | 707,791 (-74.8%) | $68.83M (-69.3%) | 3.2% | $42.33 | +143.3% | COM | 76155X100 |
| CNTA | CENTESSA PHARMACEUTICALS | 1,354,830 (-77.9%) | $53.81M (-64.8%) | 2.5% | $17.55 | — | ADS | 152309100 |
| NRIX | NURIX THERAPEUTICS | 4,101,865 (-16.2%) | $63.58M (-31.6%) | 3.0% | $14.37 | +20.7% | COM | 67080M103 |
| XP | XP, INC | 20,566,133 (-9.4%) | $392M (+5.4%) | 18.2% | $31.26 | -38.1% | CL A | G98239109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CHYM | CHIME | 21,259,683 | $398M | 18.5% | $31.82 | -24.6% | CL A | 16935C109 |
| DLO | DLOCAL | 46,656,695 | $605M | 28.2% | $34.47 | -60.6% | CL A | G29018101 |
| EWCZ | EUROPEAN WAX CENTER | 13,110,492 | $75.78M | 3.5% | $22.36 | -79.8% | CL A | 29882P106 |
| RSKD | RISKIFIED | 5,324,998 | $20.87M | 1.0% | $28.06 | -83.8% | CL A | M8216R109 |
| PHVS | PHARVARIS | 8,031,252 | $227M | 10.6% | $22.20 | +20.5% | COM | N69605108 |
| GROV | GROVE COLLABORATIVE | 2,474,859 | $3.168M | 0.1% | $1.69 | -17.4% | CL A | 39957D201 |
| BULL | WEBULL | 50,816 | $244K | 0.0% | $14.98 | -52.3% | ORD SHS | G9572D103 |